Kraft Davis & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Kraft Davis & Associates's LLY Position: Q2 2026 in Review
Kraft Davis & Associates increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $17.4K and bringing the position to 374 shares worth $457K. The position accounts for 0.1% of the portfolio, ranked #94.
Kraft Davis & Associates first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Kraft Davis & Associates held 374 shares of Eli Lilly worth $457K as of Q2 2026.
- Kraft Davis & Associates bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
- Eli Lilly made up 0.1% of Kraft Davis & Associates's portfolio in Q2 2026, its #94 holding.
- Kraft Davis & Associates first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Kraft Davis & Associates's 13F filing for Q2 2026, filed 9 Jul 2026.